Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Erasca, Inc. (ERAS), most recent 12 months reported: net loss $287.22M, free cash flow -$98.08M. Latest balance sheet on file: liquid cash $268.74M. From SEC filings. More on Erasca, Inc.: Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: ENVERIC BIOSCIENCES, INC. · GALMED PHARMACEUTICALS LTD. · EUPRAXIA PHARMACEUTICALS INC. · EQUILLIUM, INC. · Ernexa Therapeutics Inc. · Edgewise Therapeutics, Inc. · FibroBiologics, Inc. · Filana Therapeutics, Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.